ATYR vs BXP · rev $190.0K vs rev $895.7M
aTyr Pharma, Inc. (ATYR) versus Boston Properties Inc (BXP) — a side-by-side from cached financials, not a winner call.
aTyr Pharma, Inc. (ATYR) is a biotechnology company listed on US.
Boston Properties Inc (BXP) is a reit - office company listed on US.
Latest reported ATYR revenue for 2025-09-30 was $190.0K. Net income was -$25.7M. ATYR currently screens at market cap $471.7M.
Latest reported BXP revenue for 2026-06-30 was $895.7M. Net income was $68.6M. Revenue was up 2.7% from 2026-03-31 to 2026-06-30. BXP currently screens at market cap $12.12B.
ATYR currently screens at market cap $471.7M. BXP currently screens at market cap $12.12B.
Not investment advice. Open the ATYR and BXP stock pages for the full models.
Not investment advice.